retatrutide trial dose for weight loss: Study shows 30% body weight loss Doctor Explains How to Dose

High visceral fat is strongly associated with: Type 2 diabetes Cardiovascular disease Fatty liver disease Hypertension Cognitive decline Increased all-cause mortality Even individuals with a normal body mass index may carry excess visceral fat, a phenomenon often referred to as TOFI (thin outside, fat inside)

More recently, the effects of GLP-1 drugs on addiction have been studied in humans, with results so far looking very promising indeed

In the studied context, a review of six clinical trials found a safety profile comparable to placebo, without the IGF-1 effects of full growth hormone

Anderson JE

The two approaches may be complementary rather than mutually exclusive